Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 770 Shares

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 770 shares of the business’s stock in a transaction that occurred on Monday, April 6th. The shares were sold at an average price of $14.91, for a total transaction of $11,480.70. Following the completion of the sale, the chief executive officer directly owned 108,448 shares in the company, valued at $1,616,959.68. This trade represents a 0.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Thursday, April 2nd, Virgilio Deloy Capobian Gibbon sold 20,900 shares of Afya stock. The shares were sold at an average price of $14.94, for a total transaction of $312,246.00.
• On Wednesday, April 1st, Virgilio Deloy Capobian Gibbon sold 19,500 shares of Afya stock. The shares were sold at an average price of $14.98, for a total transaction of $292,110.00.
• On Tuesday, March 31st, Virgilio Deloy Capobian Gibbon sold 2,320 shares of Afya stock. The shares were sold at an average price of $14.92, for a total transaction of $34,614.40.
• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The stock was sold at an average price of $15.21, for a total transaction of $12,168.00.
• On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The stock was sold at an average price of $15.18, for a total transaction of $59,202.00.

Afya Price Performance

Shares of AFYA opened at $14.99 on Tuesday. Afya Limited has a fifty-two week low of $13.00 and a fifty-two week high of $19.90. The firm’s 50 day moving average price is $14.48 and its 200 day moving average price is $14.70. The company has a market cap of $1.40 billion, a P/E ratio of 10.27, a PEG ratio of 0.67 and a beta of 0.48. The company has a quick ratio of 0.98, a current ratio of 2.20 and a debt-to-equity ratio of 0.21.

Afya (NASDAQ:AFYA) last announced its earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The firm had revenue of $147.08 million for the quarter, compared to the consensus estimate of $174.74 million. On average, research analysts forecast that Afya Limited will post 1.52 earnings per share for the current fiscal year.

Afya Announces Dividend

The firm also recently announced an annual dividend, which was paid on Monday, April 6th. Investors of record on Wednesday, March 25th were paid a dividend of $0.656 per share. This represents a yield of 433.0%. The ex-dividend date of this dividend was Wednesday, March 25th. Afya’s dividend payout ratio is presently 45.21%.

Institutional Investors Weigh In On Afya

A number of large investors have recently modified their holdings of AFYA. Daiwa Securities Group Inc. purchased a new stake in shares of Afya in the 4th quarter valued at approximately $43,000. Militia Capital Partners LP purchased a new stake in shares of Afya in the 2nd quarter valued at approximately $71,000. Quantbot Technologies LP purchased a new stake in shares of Afya in the 2nd quarter valued at approximately $117,000. Van ECK Associates Corp increased its position in shares of Afya by 15.7% in the 3rd quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after purchasing an additional 1,377 shares during the last quarter. Finally, State of Wyoming purchased a new stake in shares of Afya in the 2nd quarter valued at approximately $164,000. 88.02% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently weighed in on AFYA. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research note on Friday, January 16th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $22.00 target price (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. Zacks Research raised shares of Afya from a “strong sell” rating to a “hold” rating in a research report on Monday, March 9th. UBS Group reissued a “neutral” rating and issued a $16.00 price objective (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, Afya has an average rating of “Hold” and an average price target of $17.30.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.